4.3 Article

Hospitalization and mortality among pediatric cancer survivors: a population-based study

期刊

CANCER CAUSES & CONTROL
卷 29, 期 11, 页码 1047-1057

出版社

SPRINGER
DOI: 10.1007/s10552-018-1078-0

关键词

Childhood cancer; Hospitalization; Late effects; Survivorship; Cohort; Morbidity

资金

  1. Alex's Lemonade Stand Foundation for Childhood Cancer
  2. National Cancer Institute [HHSN261201300012I]
  3. Centers for Disease Control and Prevention [DP12-1205 DP003899-02]

向作者/读者索取更多资源

PurposeWe examined serious long-term outcomes among childhood cancer survivors using population-based data.MethodsWe used 1982-2014 Washington State data to compare hospitalization and/or death (including cause-specific) during up to 27years follow-up among all 5+ year childhood cancer survivors <20years at diagnosis (n=3,152) and a sample of comparison children within birth cohorts, with assessment by cancer type and child/family characteristics.ResultsDuring follow-up (9years median), 12% of survivors had hospitalizations; 4% died. Greatest absolute risks/1,000 person-years were for hospitalization/deaths due to cancers (8.1), infection (6.2), injuries (6.0), and endocrine/metabolic disorders (5.8). Hazard ratios (HR) and 95% confidence intervals (CI) for hospitalization (2.7, 95% CI 2.4-3.0) and any-cause death (14.7, 95% CI 11.3-19.1) were increased, and for all cause-specific outcomes examined, most notably cancer- (35.1, 95% CI 23.7-51.9), hematological- (6.7, 95% CI 5.3-8.5), nervous system- (6.4, 95% CI 5.2-7.8), and circulatory- (5.2, 95% CI 4.1-6.5) related outcomes. Hospitalizations occurred more often among females and those receiving radiation, with modest differences by urban/rural birth residence and race/ethnicity. Cause-specific outcomes varied by cancer type.ConclusionsThis study suggests increased risks for the rarely-studied outcomes of long-term fracture and injury, and confirms increased risks of selected other conditions among survivors. Multi-state pooling of population-based data would increase the ability to evaluate outcomes for uncommon cancer types and by racial/ethnic groups under-represented in many studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据